Fludarabine phosphate for the first-line treatment of chronic lymphocytic leukaemia
Walker S, Palmer S, Erhorn S, Brent S, Dyker A, Ferrie L, Horsley W, Macfarlane K, White S, Thomas S
Record ID 32011001401
English
Authors' recommendations:
To enable an accurate assessment to be made of the clinical and cost-effectiveness of fludarabine as first-line treatment for chronic lymphocytic leukaemia there is a need for further evidence to clarify areas of uncertainty.
Details
Project Status:
Completed
Year Published:
2009
URL for published report:
http://www.hta.ac.uk/1639
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
England, United Kingdom
MeSH Terms
- Clinical Trials as Topic
- Quality of Life
- Survival Analysis
- Technology Assessment, Biomedical
- Antineoplastic Agents
- Leukemia, Lymphocytic, Chronic, B-Cell
- Vidarabine
Contact
Organisation Name:
NIHR Health Technology Assessment programme
Contact Address:
NIHR Journals Library, National Institute for Health and Care Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton SO16 7NS, UK
Contact Name:
journals.library@nihr.ac.uk
Contact Email:
journals.library@nihr.ac.uk
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.